Cargando…

In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2

A serious pandemic has been caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The interaction between spike surface viral protein (Sgp) and the angiotensin-converting enzyme 2 (ACE2) cellular receptor is essential to understand the SARS-CoV-2 infectivity and pathogenicity....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liscano, Yamil, Oñate-Garzón, Jose, Ocampo-Ibáñez, Iván Darío
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728342/ https://www.ncbi.nlm.nih.gov/pubmed/33255849 http://dx.doi.org/10.3390/molecules25235535

Ejemplares similares

Integrating In Vitro and In Silico Analysis of a Cationic Antimicrobial Peptide Interaction with Model Membranes of Colistin-Resistant Pseudomonas aeruginosa Strains
por: Rivera-Sanchez, Sandra Patricia, et al.
Publicado: (2022)

Characterization and Classification In Silico of Peptides with Dual Activity (Antimicrobial and Wound Healing)
por: Trejos, María, et al.
Publicado: (2023)

Peptides with Dual Antimicrobial–Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides
por: Liscano, Yamil, et al.
Publicado: (2020)

A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Ocampo-Ibáñez, Iván Darío, et al.
Publicado: (2020)

Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical Pseudomonas aeruginosa
por: Laverde-Rojas, Valentina, et al.
Publicado: (2020)

In Silico Selection and Evaluation of Pugnins with Antibacterial and Anticancer Activity Using Skin Transcriptome of Treefrog (Boana pugnax)
por: Liscano, Yamil, et al.
Publicado: (2021)

In Silico Characterization of the Interaction between the PBP2a “Decoy” Protein of Resistant Staphylococcus aureus and the Monomeric Units of Eudragit E-100 and Poly(Maleic Acid-alt-Octadecene) Polymers
por: Liscano, Yamil, et al.
Publicado: (2021)

Specific Focus on Antifungal Peptides against Azole Resistant Aspergillus fumigatus: Current Status, Challenges, and Future Perspectives
por: Pimienta, Dilan Andrés, et al.
Publicado: (2022)

A Study of the Interaction of a New Benzimidazole Schiff Base with Synthetic and Simulated Membrane Models of Bacterial and Mammalian Membranes
por: Aragón-Muriel, Alberto, et al.
Publicado: (2021)

Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria
por: Liscano, Yamil, et al.
Publicado: (2019)

In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein
por: Bansal, Ritu, et al.
Publicado: (2021)

Synthesis, biological evaluation and model membrane studies on metal complexes containing aromatic N,O-chelate ligands
por: Aragón-Muriel, Alberto, et al.
Publicado: (2020)

Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains: Classification, Structures, and Mechanisms of Action
por: Hernández-Aristizábal, Isabella, et al.
Publicado: (2021)

Antibacterial Activity of a Cationic Antimicrobial Peptide against Multidrug-Resistant Gram-Negative Clinical Isolates and Their Potential Molecular Targets
por: Rivera-Sánchez, Sandra Patricia, et al.
Publicado: (2020)

Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
por: Kurpe, Stanislav R., et al.
Publicado: (2020)

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
por: Wen, Lei, et al.
Publicado: (2021)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

In silico analysis of protein/peptide-based inhalers against SARS-CoV-2
por: Salman, Saad, et al.
Publicado: (2020)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

A tree frog (Boana pugnax) dataset of skin transcriptome for the identification of biomolecules with potential antimicrobial activities
por: Liscano Martinez, Yamil, et al.
Publicado: (2020)

In Vitro Evaluation of the Potential Pharmacological Activity and Molecular Targets of New Benzimidazole-Based Schiff Base Metal Complexes
por: Aragón-Muriel, Alberto, et al.
Publicado: (2021)

Development, Characterization, and Antimicrobial Evaluation of Ampicillin-Loaded Nanoparticles Based on Poly(maleic acid-co-vinylpyrrolidone) on Resistant Staphylococcus aureus Strains
por: Salamanca, Constain H., et al.
Publicado: (2022)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review
por: Dueñas, Diana, et al.
Publicado: (2023)

In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
por: Ibrahim, Mahmoud A.A., et al.
Publicado: (2020)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein
por: Wang, Qing, et al.
Publicado: (2023)

In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations
por: Khan, Abbas, et al.
Publicado: (2021)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach
por: Kesarwani, Veerbhan, et al.
Publicado: (2021)

Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
por: Campos-Ruíz, Mario Aldair, et al.
Publicado: (2023)

Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction
Publicado: (2020)

Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021)

In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection
por: Badhe, Yogesh, et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
por: Ibrahim, Mahmoud A.A., et al.
Publicado: (2021)

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery
por: Khattab, Amira R, et al.
Publicado: (2022)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g45atn512urrqhgkuj7ib58a5s